• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 1320 páginas
Examen

Goodman & Gilman’s The Pharmacological Basis of Therapeutics 14th Edition Test Bank – All Chapters Full Coverage Pharmacology & Therapeutics Exam Prep

Document preview thumbnail
Vista previa 4 fuera de 1320 páginas

Original educational test bank aligned with Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 14th Edition, with comprehensive full-textbook coverage. Designed for medical, pharmacy, nursing, and healthcare students preparing for pharmacology exams, it reinforces mechanisms of drug action, pharmacokinetics, pharmacodynamics, therapeutic applications, adverse effects, toxicity, contraindications, drug interactions, and clinical reasoning. Use it as a focused study resource for reviewing core pharmacology and therapeutics concepts across the text. It supports focused exam preparation 1. Goodman & Gilman 14th Edition Test Bank 2. Goodman Gilman Pharmacology Test Bank 3. Pharmacology and Therapeutics Exam Prep 4. Clinical Pharmacology Questions Study Resource 5. Pharmacokinetics Pharmacodynamics Test Bank

Vista previa del contenido

TEST BANK




Goodman and Gilman's The
Pharmacological Basis of Therapeutics
14th Edition


Author(s)Laurence Brunton; Bjorn Knollmann
Print ISBN: 9781264258079

,Question 1
A research team identifies a plant traditionally used to relieve fever and
decides to investigate it as a potential source of a new therapeutic
agent. Which step is most appropriate early in the drug-discovery
process?
A. Administer the whole plant preparation to patients in a phase III trial
B. Isolate and characterize potentially active chemical constituents

,C. Begin large-scale manufacturing of the plant extract
D. Determine the drug's postmarketing adverse-event profile
Correct Answer: B. Isolate and characterize potentially active chemical
constituents
Rationale:
B is correct because medicinal plants can serve as sources of bioactive
compounds, but the active constituents must be identified and
characterized before systematic development. A is inappropriate
because clinical trials require adequate preclinical characterization and
safety information. C is premature before an active candidate has been
established. D occurs after a drug has reached clinical use and therefore
is not an early discovery step.
Question 2
Which characteristic makes a natural product particularly valuable as a
starting point for drug discovery?
A. It is automatically safe in humans
B. It necessarily has high oral bioavailability
C. It may contain a structurally complex molecule with useful biological
activity
D. It has already satisfied regulatory requirements
Correct Answer: C. It may contain a structurally complex molecule with
useful biological activity
Rationale:
C is correct because natural products can provide chemically diverse
structures that interact with biological targets and may serve as leads
for drug development. A is incorrect because natural origin does not

, guarantee safety. B is incorrect because absorption and bioavailability
must be experimentally determined. D is incorrect because discovery
from a natural source does not establish regulatory approval.
Question 3
A compound isolated from a medicinal plant produces a promising
biological effect in an initial assay. Researchers then modify its chemical
structure to improve its properties. What is this process primarily
intended to accomplish?
A. Convert the compound into a placebo
B. Optimize the compound as a drug lead
C. Eliminate the need for biological testing
D. Replace pharmacological evaluation with chemical analysis
Correct Answer: B. Optimize the compound as a drug lead
Rationale:
B is correct because structural modification of an active compound can
improve properties such as potency, selectivity, pharmacokinetic
behavior, or tolerability. A is unrelated to lead optimization. C is
incorrect because modified compounds still require biological
evaluation. D is incorrect because chemical modification and biological
testing are complementary components of drug discovery.
Question 4
A medicinal chemist wants to determine which structural features of a
lead compound are responsible for its biological activity. Which
approach is most directly useful?

Libro relacionado
 image
Editorial: 2022 ISBN: 9781264258079 Edición: Desconocido

Información del documento

Subido en
6 de octubre de 2026
Número de páginas
1320
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$30.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
0
Seguidores
0
Artículos
27
Última venta
-



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes